Gengshi Chen

Gengshi Chen is a Health Economics and Payer Evidence Director with extensive experience in health economics and analytics. They served as a Health Economics Manager at AstraZeneca from 2018 to 2021 and played a pivotal role at Costello Medical, where they relocated to Singapore to help establish the Asia-Pacific regional office. Gengshi holds a Master of Science in Economic Evaluation for Health Technology Assessment from the University of York, as well as an MSci and BA in Biochemistry from the University of Cambridge. They have contributed to various projects involving HTA submissions, health economic publications, and real-world evidence generation.